Omlonti is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Santen Incorporated. The primary component is Omidenepag Isopropyl.
Product ID | 65086-002_e9ecbd7e-ef67-5759-e053-2995a90ab5ee |
NDC | 65086-002 |
Product Type | Human Prescription Drug |
Proprietary Name | Omlonti |
Generic Name | Omidenepag Isopropyl |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2022-09-23 |
Marketing Category | NDA / |
Application Number | NDA215092 |
Labeler Name | Santen Incorporated |
Substance Name | OMIDENEPAG ISOPROPYL |
Active Ingredient Strength | 0 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OMLONTI 79227958 5640040 Live/Registered |
Santen Pharmaceutical Co., Ltd. 2017-11-13 |